This company listing is no longer active
AusCann Group Holdings 과거 수익 실적
과거 기준 확인 0/6
AusCann Group Holdings's earnings have been declining at an average annual rate of -3.6%, while the Pharmaceuticals industry saw earnings growing at 35.6% annually. Revenues have been growing at an average rate of 50.2% per year.
주요 정보
-3.6%
수익 성장률
10.7%
EPS 성장률
| Pharmaceuticals 산업 성장 | 31.2% |
| 매출 성장률 | 50.2% |
| 자기자본 수익률 | -137.4% |
| 순이익 | -1,224.0% |
| 최근 수익 업데이트 | 30 Jun 2022 |
최근 과거 실적 업데이트
수익 및 비용 분석
AusCann Group Holdings 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 30 Jun 22 | 2 | -25 | 3 | 0 |
| 31 Mar 22 | 2 | -17 | 3 | 0 |
| 31 Dec 21 | 2 | -9 | 4 | 0 |
| 30 Sep 21 | 2 | -10 | 4 | 0 |
| 30 Jun 21 | 2 | -11 | 5 | 0 |
| 31 Dec 20 | 1 | -8 | 5 | -1 |
| 30 Sep 20 | 1 | -7 | 5 | 0 |
| 30 Jun 20 | 1 | -7 | 5 | 0 |
| 31 Mar 20 | 1 | -7 | 5 | 0 |
| 31 Dec 19 | 1 | -7 | 5 | 0 |
| 30 Sep 19 | 1 | -7 | 4 | 0 |
| 30 Jun 19 | 1 | -8 | 4 | 0 |
| 31 Mar 19 | 0 | -7 | 4 | 0 |
| 31 Dec 18 | 0 | -7 | 5 | 1 |
| 30 Sep 18 | 0 | -7 | 6 | 0 |
| 30 Jun 18 | 0 | -8 | 7 | 0 |
| 31 Mar 18 | 0 | -13 | 8 | 0 |
| 31 Dec 17 | 0 | -18 | 9 | 0 |
| 30 Sep 17 | 0 | -16 | 8 | 0 |
| 30 Jun 17 | 0 | -14 | 6 | 0 |
| 31 Mar 17 | 0 | -11 | 7 | 0 |
| 31 Dec 16 | 0 | -7 | 7 | 0 |
| 30 Sep 16 | 0 | -6 | 6 | 0 |
양질의 수익: AC8 is currently unprofitable.
이익 마진 증가: AC8 is currently unprofitable.
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: AC8 is unprofitable, and losses have increased over the past 5 years at a rate of 3.6% per year.
성장 가속화: Unable to compare AC8's earnings growth over the past year to its 5-year average as it is currently unprofitable
수익 대 산업: AC8 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (28.2%).
자기자본 수익률
높은 ROE: AC8 has a negative Return on Equity (-137.39%), as it is currently unprofitable.